Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.
about
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineTP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerPrognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXCan biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Hereditary ovarian cancer: not only BRCA 1 and 2 genes.RADIA: RNA and DNA integrated analysis for somatic mutation detection.Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical OutcomesTP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancerBreast Cancer Biomarkers: Utility in Clinical Practice.Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activityMapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.Optimal adjuvant chemotherapy in breast cancer: selection of agents.Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway.Somatic TP53 Mutations in the Era of Genome Sequencing.Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer.
P2860
Q26853619-582D4766-66BE-4F12-8554-EE063EC6A468Q33566957-9D11C390-D5E2-499C-919F-E0156F8980D0Q33739357-4180EA21-1530-4325-BFF2-CDAB78014B89Q33820233-8881CF5D-C0B4-42E0-98C4-E999322E8073Q34324683-7957B6EE-694E-4644-9604-1927E3183CDDQ34480707-4D9A20A5-4F29-4160-B203-8244A7CC5BE4Q34535183-04F71AB8-9D67-4804-9F0F-9CC9E6739BB9Q35726998-A76B710C-0A69-4AD5-9248-0C74C9F29ED0Q36376097-6210AD69-D29F-4727-8542-485504D78276Q37225619-F5A3D012-834E-45D5-A410-33E7E5C54189Q37441159-00A751C6-7E4E-46F6-87C6-D50641CDEC74Q37678950-4C7F1311-DD0B-4727-90AF-F02E60C312AEQ37680206-0A9218E4-E5A6-49AF-841C-24F660E49AF5Q38087850-D775E159-105C-47AC-8696-E78FFE5EF832Q38235713-7CA7C804-8B60-4B0B-9AC7-0DE26E5A15F8Q38715267-2CFF74F8-DF84-4FEE-93E1-008BB11C64D6Q38922539-12BF177D-053D-4115-88EC-C37C876DCDA0Q55008104-A35A82A3-3875-4F6A-893E-579FE06314B3
P2860
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prognostic and predictive valu ...... the BIG 02-98 phase III trial.
@ast
Prognostic and predictive valu ...... the BIG 02-98 phase III trial.
@en
type
label
Prognostic and predictive valu ...... the BIG 02-98 phase III trial.
@ast
Prognostic and predictive valu ...... the BIG 02-98 phase III trial.
@en
prefLabel
Prognostic and predictive valu ...... the BIG 02-98 phase III trial.
@ast
Prognostic and predictive valu ...... the BIG 02-98 phase III trial.
@en
P2093
P2860
P50
P356
P1476
Prognostic and predictive valu ...... the BIG 02-98 phase III trial.
@en
P2093
Catherine Oakman
Denis Larsimont
John Crown
Ke-Seay Smoth
Lynnette Fernández-Cuesta
M Stella Dolci
Patrizia Dell'orto
Priscila Falagan-Lotsch
P2860
P2888
P356
10.1186/BCR3179
P50
P577
2012-05-02T00:00:00Z
P5875
P6179
1012055898